Dr. Jolie L. Chang, MD

Dr. Chang practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Chang's NPI, 1083856967, was assigned on March 24, 2009. Dr. Chang graduated from UCSF School of Medicine in 2006. Dr. Chang holds California license A106597.

Dr. Chang's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Chang's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Chang to 4 more group practices and clinics and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chang practices, 5 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Chang's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Chang is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dr. Chang is licensed in California.

Dmand AI lists hearing loss and impairment, tinnitus and vertigo among the conditions Dr. Chang treats.

CMS data shows 252 Medicare services from Dr. Chang across 6 procedure codes in 2024, for 139 Medicare patients. Medicare paid $20,129 for them. Every service was in an office.

CMS counts 139 Medicare patients who saw Dr. Chang in 2024. The largest group is 65 to 74, with 71 patients. 75% of them have high cholesterol, and 65% have high blood pressure. 19% are also on Medicaid. Their average risk score is 0.91, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Chang's median patient age at 64, with 54% women.

In 2024, Dr. Chang wrote 45 Medicare Part D claims for 17 patients. 98% of them were for generic drugs. CMS names the drug for 17 of them, across 1 drug with 11 or more claims each, at $78 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Chang for performance year 2024, reported as part of a group. Dr. Chang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chang as offering telehealth.

Dmand AI links 86 papers to Dr. Chang, published from 2012 to 2025. 2024 was the busiest year, with 13. The most frequent topics are Sleep Apnea, Obstructive, Endoscopy and Sialadenitis. Dr. Chang has published most often in Laryngoscope. Dr. Chang's most frequent co-authors are Steven W. Cheung, MD, Megan Leigh Durr, MD and William Russell Ryan, MD.

Dmand AI links Dr. Chang to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Sleep Apnea, Obstructive and Signs and Symptoms, Respiratory.

CMS Open Payments shows 78 general payments to Dr. Chang from 11 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 73% of the total. Inspire Medical Systems, Inc. paid the most, $47,507.

Dmand AI lists 3 awards for Dr. Chang, most recently CMS Stage 1 EHR in 2012.

Dr. Chang graduated from UCSF School of Medicine in 2006. Dr. Chang is a member of NHS and Triological Society.

Dr. Chang is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.